🔎 Trials Near Me

Hjem › Pladecellekarcinom › Maryland

Pladecellekarcinom kliniske forsøg i Maryland

4 studier for Pladecellekarcinom søger deltagere på steder i Maryland.

Byer i Maryland

Officiel studietekst (engelsk)

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • University of Maryland Medical Center, Baltimore
  • National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 2. sep. 2026 · NCT04915183

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 72 · Alle køn · Opdateret 31. aug. 2026 · NCT02133196

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

  • Johns Hopkins Hospital East Baltimore, Baltimore
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. apr. 2026 · NCT07209189

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • University of Maryland, Baltimore
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. apr. 2026 · NCT06064877

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.